FDA permits marketing of mobile medical application for substance use disorder

Last month, the U.S. Food and Drug Administration permitted marketing of the first mobile medical application to help treat substance use disorder (SUD). The Reset application is intended to be used with outpatient therapy to treat alcohol, cocaine, marijuana, and stimulant SUDs. The application is not intended to be used to treat opioid dependence.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fcpu.30251

Source: The Brown University Child and Adolescent Psychopharmacology Update - September 25, 2017 Category: Psychiatry Tags: From the FDA Source Type: research

More News: Alcoholism | Children | Food and Drug Administration (FDA) | Marketing